Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
Abstract Background The current study aimed to evaluate growth and neurodevelopmental status in patients with retinopathy of prematurity (ROP) treated with intravitreal bevacizumab (IVB). Methods This historical cohort study was conducted on neonates with ROP who were treated with IVB and age and bi...
Guardado en:
Autores principales: | Majid Abrishami, Hassan Boskabadi, Mojtaba Abrishami, Farid Shekarchian, Majid Khadem-Rezaiyan, Nasser Shoeibi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0d3a9cf2371a456f83ee93a4d6ca78bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity
por: Obata S, et al.
Publicado: (2019) -
Axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for retinopathy of prematurity
por: Lin CJ, et al.
Publicado: (2016) -
Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
por: Fouzdar Jain S, et al.
Publicado: (2018) -
Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
por: Ribeiro de Carvalho G, et al.
Publicado: (2020) -
Outcomes of Pre-Early Treatment for Retinopathy of Prematurity (Pre-ETROP)
por: Titawattanakul Y, et al.
Publicado: (2020)